drugset / Trial / NCT00275665
The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.
Phase 3
Completed
20 enrolled
Mayo Clinic
City of Hope National Medical Center · collabFred Hutchinson Cancer Center · collabRoche Pharma AG · collabUniversity of Florida · collabUniversity of Michigan · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is being done in stem cell transplant recipients to see if taking the drug valganciclovir can prevent or reduce serious cytomegalovirus (CMV) infections that can occur 100 days or later after transplant.
Timeline
- Start
- 2001-11
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valganciclovir | Small molecule | — | — |